TY027 / Tychan 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  TY027 / Tychan
    Enrollment change, Trial termination, Trial primary completion date:  Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans (clinicaltrials.gov) -  Mar 24, 2022   
    P3,  N=17, Terminated, 
    N=1305 --> 17 | Recruiting --> Terminated | Trial primary completion date: Aug 2021 --> Mar 2022; Low recruitment rate
  • ||||||||||  TY027 / Tychan
    Trial completion:  Safety of TY027, a Treatment for COVID-19, in Humans (clinicaltrials.gov) -  Apr 8, 2021   
    P1,  N=32, Completed, 
    N=1305 --> 17 | Recruiting --> Terminated | Trial primary completion date: Aug 2021 --> Mar 2022; Low recruitment rate Active, not recruiting --> Completed
  • ||||||||||  TY027 / Tychan
    Enrollment closed:  Safety of TY027, a Treatment for COVID-19, in Humans (clinicaltrials.gov) -  Sep 23, 2020   
    P1,  N=32, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting